1. Home
  2. SBET vs NUVB Comparison

SBET vs NUVB Comparison

Compare SBET & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SharpLink Gaming Ltd.

SBET

SharpLink Gaming Ltd.

HOLD

Current Price

$7.50

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$4.76

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBET
NUVB
Founded
1995
2018
Country
United States
United States
Employees
N/A
298
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
SBET
NUVB
Price
$7.50
$4.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
8
Target Price
$18.71
$11.38
AVG Volume (30 Days)
7.0M
4.0M
Earning Date
05-11-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$28,055,000.00
N/A
Revenue This Year
$105.19
$203.82
Revenue Next Year
$13.53
$58.18
P/E Ratio
N/A
N/A
Revenue Growth
666.04
N/A
52 Week Low
$2.58
$1.57
52 Week High
$124.12
$9.75

Technical Indicators

Market Signals
Indicator
SBET
NUVB
Relative Strength Index (RSI) 53.77 50.85
Support Level $6.05 $4.06
Resistance Level $8.26 $5.42
Average True Range (ATR) 0.35 0.33
MACD 0.03 0.01
Stochastic Oscillator 62.69 54.70

Price Performance

Historical Comparison
SBET
NUVB

About SBET SharpLink Gaming Ltd.

SharpLink Inc is one of those publicly traded companies to adopt ETH as its primary treasury reserve asset. This move reflects the Company's commitment to align corporate treasury with the future of programmable finance, digital capital markets, and decentralized infrastructure. The Company also operates an online affiliate marketing company that delivers different fan activation solutions to its sportsbook and online casino gaming partners. The company operates in two reportable segments: ETH Treasury Management and Affiliate Marketing. The majority of its revenue is generated from the ETH Treasury Management. Geographically, the company operates in the United States and the rest of the world.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: